Cleared Traditional

CLEX (K833463) - FDA 510(k) Clearance

Class I Hematology device.

K833463 · Dextran Products, Ltd. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1983
Decision
47d
Days
Class 1
Risk

K833463 is an FDA 510(k) clearance for the CLEX. Classified as Sera, Animal And Human (product code KIS), Class I - General Controls.

Submitted by Dextran Products, Ltd. (Mchenry, US). The FDA issued a Cleared decision on November 21, 1983 after a review of 47 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.2800 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dextran Products, Ltd. devices

Submission Details

510(k) Number K833463 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 05, 1983
Decision Date November 21, 1983
Days to Decision 47 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 113d · This submission: 47d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KIS Sera, Animal And Human
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.2800
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.